Glipten

Glipten

teneligliptin

Manufacturer:

Ajanta Pharma Phil

Distributor:

Ajanta Pharma Phil
Concise Prescribing Info
Contents
Teneligliptin hydrobromide hydrate
Indications/Uses
Type 2 DM as monotherapy or in combination w/ other oral hypoglycemic agents & insulin.
Dosage/Direction for Use
20 mg once daily. May be increased to 40 mg once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Severe ketosis, diabetic coma or history of diabetic coma, type 1 diabetes, severe infection or trauma, surgery.
Special Precautions
Heart failure NYHA classification III-IV. Pituitary or adrenal insufficiency, poor nutritional state, starvation, irregular food intake or debilitating condition, intensive exercise or excessive alcohol intake. Patients taking medication that may enhance blood glucose lowering effect of teneligliptin (β-blockers, MAOIs) or attenuate blood glucose lowering effect of teneligliptin (steroids, thyroid hormones). History of bowel obstruction or abdominal surgery. Concomitant use w/ sulfonylureas or insulin. Patients who are prone to QT prolongation, w/ existing or w/ history of arrhythmia, bradycardia, heart failure, low serum K, Torsades de pointes, patients using antiarrhythmic drugs (Class IA & III). Severe hepatic impairment. Pregnancy & lactation.
Drug Interactions
Increased Cmax & AUC w/ ketoconazole. Increased risk of hypoglycemia w/ insulin & insulin secretagogues eg, sulfonylureas & glinides.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BH08 - teneligliptin ; Belongs to the class of dipeptidyl peptidase 4 (DPP-4) inhibitors. Used in the treatment of diabetes.
Presentation/Packing
Form
Glipten FC tab 20 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in